Reps Schrier, Langworthy Introduce Bipartisan Bill to Lower Prescription Drug Costs by Expanding Access to Biosimilars
biologic. Our bipartisan bill cuts unnecessary red tape, provides greater regulatory certainty, and helps bring lower-cost treatment … process if additional clinical studies will be required, providing greater certainty and helping avoid unnecessary delays. The legislation